CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma

Xin Fan1, Xiaoyan Ma2, Lei Cui1

  • 1Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, PR China.

Oncotarget
|November 10, 2016
PubMed

Insights

Collaborator of ARF (CARF) promotes hepatocellular carcinoma (HCC) growth by activating beta-catenin signaling. Targeting CARF may offer new therapeutic strategies for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Ras signaling pathway overactivation is common in hepatocellular carcinoma (HCC).
  • Targeting Ras directly is challenging, necessitating identification of downstream effectors.
  • CARF (collaborator of ARF) was investigated as a potential Ras effector in HCC.

Purpose of the Study:

  • To investigate the role of CARF in HCC tumorigenesis.
  • To elucidate the mechanism by which CARF influences HCC progression.
  • To evaluate CARF as a potential therapeutic target for HCC.

Main Methods:

  • Utilized a genetically engineered mouse model (Alb-Cre; P53f/f; Loxp-Stop-Loxp-RasG12D) of HCC.
  • Analyzed CARF expression in HCC mouse models and human HCC samples.
  • Performed gain-of-function and loss-of-function studies on HCC cells (overexpression and knockdown of CARF).
  • Investigated CARF's interaction with beta-catenin and its effect on beta-catenin/TCF signaling.

Main Results:

  • CARF expression is induced by oncogenic RasV12 and upregulated in HCC.
  • CARF overexpression promotes HCC cell growth and migration.
  • CARF knockdown inhibits HCC cell growth, migration, and tumorigenesis.
  • CARF interacts with beta-catenin, disrupts beta-catenin/ICAT interaction, and activates beta-catenin/TCF signaling.

Conclusions:

  • CARF functions as an oncogene in HCC tumorigenesis.
  • CARF promotes HCC by activating beta-catenin/TCF signaling.
  • CARF represents a potential therapeutic target for HCC treatment.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K